Cargando…

The disease formerly known as rheumatoid arthritis

Rheumatoid arthritis is a complex disease where predetermined and stochastic factors conspire to confer disease susceptibility. In light of the diverse responses to targeted therapies, rheumatoid arthritis might represent a final common clinical phenotype that reflects many pathogenic pathways. Ther...

Descripción completa

Detalles Bibliográficos
Autor principal: Firestein, Gary S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075245/
https://www.ncbi.nlm.nih.gov/pubmed/25167330
http://dx.doi.org/10.1186/ar4593
_version_ 1782323312213360640
author Firestein, Gary S
author_facet Firestein, Gary S
author_sort Firestein, Gary S
collection PubMed
description Rheumatoid arthritis is a complex disease where predetermined and stochastic factors conspire to confer disease susceptibility. In light of the diverse responses to targeted therapies, rheumatoid arthritis might represent a final common clinical phenotype that reflects many pathogenic pathways. Therefore, it might be appropriate to begin thinking about rheumatoid arthritis as a syndrome rather than a disease. Use of genetics, epigenetics, microbiomics, and other unbiased technologies will probably permit stratification of patients based on mechanisms of disease rather than by clinical phenotype.
format Online
Article
Text
id pubmed-4075245
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40752452014-12-26 The disease formerly known as rheumatoid arthritis Firestein, Gary S Arthritis Res Ther Commentary Rheumatoid arthritis is a complex disease where predetermined and stochastic factors conspire to confer disease susceptibility. In light of the diverse responses to targeted therapies, rheumatoid arthritis might represent a final common clinical phenotype that reflects many pathogenic pathways. Therefore, it might be appropriate to begin thinking about rheumatoid arthritis as a syndrome rather than a disease. Use of genetics, epigenetics, microbiomics, and other unbiased technologies will probably permit stratification of patients based on mechanisms of disease rather than by clinical phenotype. BioMed Central 2014 2014-06-26 /pmc/articles/PMC4075245/ /pubmed/25167330 http://dx.doi.org/10.1186/ar4593 Text en Copyright © 2014 Firestein; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 The licensee has exclusive rights to distribute this article, in any medium, for 6 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Firestein, Gary S
The disease formerly known as rheumatoid arthritis
title The disease formerly known as rheumatoid arthritis
title_full The disease formerly known as rheumatoid arthritis
title_fullStr The disease formerly known as rheumatoid arthritis
title_full_unstemmed The disease formerly known as rheumatoid arthritis
title_short The disease formerly known as rheumatoid arthritis
title_sort disease formerly known as rheumatoid arthritis
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075245/
https://www.ncbi.nlm.nih.gov/pubmed/25167330
http://dx.doi.org/10.1186/ar4593
work_keys_str_mv AT firesteingarys thediseaseformerlyknownasrheumatoidarthritis
AT firesteingarys diseaseformerlyknownasrheumatoidarthritis